STOCK TITAN

UL Solutions SEC Filings

ULS NYSE

Welcome to our dedicated page for UL Solutions SEC filings (Ticker: ULS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

UL Solutions Inc. (NYSE: ULS) files a range of documents with the U.S. Securities and Exchange Commission that shed light on its operations as a global applied safety science and specialty business services company. On this page, Stock Titan connects those filings with AI‑powered summaries to help readers interpret the information more efficiently.

For UL Solutions, current reports on Form 8‑K provide insight into material events. Examples include disclosures about secondary public offerings of Class A common stock by a selling stockholder, where the company notes that it did not receive proceeds from the share sales, and a credit agreement establishing a senior unsecured multi‑currency revolving credit facility that includes a consolidated net leverage covenant and conditions on dividends. Other 8‑K filings discuss an expense reduction and restructuring plan focused on exiting certain non‑strategic lines of business and leadership changes among senior executives.

In addition to 8‑K reports, investors typically review annual reports on Form 10‑K and quarterly reports on Form 10‑Q for details on UL Solutions’ testing, inspection and certification operations, software and advisory offerings, segment information and risk factors. While these specific forms are not reproduced here, they are accessible through the SEC’s EDGAR system and are summarized on Stock Titan when available.

Stock Titan’s tools surface key elements from UL Solutions’ filings, such as descriptions of credit facilities, restructuring plans, capital markets transactions and governance updates. The platform also highlights exhibits referenced in 8‑K filings, including underwriting agreements and legal opinions, so that users can understand how financing arrangements and other contracts relate to the company’s broader business. This page is designed to make it easier to follow UL Solutions’ regulatory disclosures without reading every document in full.

Rhea-AI Summary

UL Solutions Inc. reported an update to a director’s deferred equity holdings based on dividend accruals. On 12/08/2025, the director received 8 dividend equivalent rights tied to deferred restricted stock units, each representing a contingent right to one share of Class A common stock. The director also received 4 additional dividend equivalent rights linked to another deferred restricted stock unit award, all at a price of $0.

The dividend equivalent rights tied to units that vested on May 1, 2025 are expected to be settled in Class A common shares on a date the director selects under the company’s Non-Employee Director Deferred Compensation Plan, or as otherwise provided by the plan. The remaining rights will vest on the earlier of May 20, 2026 or the next annual meeting following the grant date, and are also expected to be settled in shares under the same plan. After these transactions, the director beneficially owns 4,954 and 2,801 derivative securities in the respective deferred unit accounts.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

UL Solutions Inc. director reports dividend-equivalent awards on deferred stock units. A company director filed a Form 4 showing automatic accrual of dividend equivalent rights on existing deferred restricted stock units, tied to UL Solutions Class A common stock.

On December 8, 2025, the director received 8 dividend equivalent rights linked to deferred restricted stock units that vested on May 1, 2025, and 4 dividend equivalent rights linked to a separate deferred restricted stock unit grant that will vest on the earlier of May 20, 2026 or the next annual meeting after the grant date. Each right represents a contingent claim to one share of Class A common stock, at a price of $0, under the company’s Non-Employee Director Deferred Compensation Plan.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

UL Solutions Inc. reported insider equity activity by its Executive VP & CFO, Ryan Robinson. On December 8, 2025, he acquired dividend equivalent rights in the form of restricted stock units (RSUs) that track the company’s Class A common stock at an exercise price of $0. One grant added 16 RSUs, bringing the related holding to 9,718 RSUs, while another added 15 RSUs, bringing that holding to 9,267 RSUs.

Each dividend equivalent right represents a contingent right to receive one share of Class A common stock and accrues on existing RSUs. These dividend equivalents vest on the same schedule as the underlying RSUs, in three equal installments on the first, second, and third anniversaries of May 1, 2024 and April 1, 2025, respectively.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

UL Solutions Inc. reported that one of its directors acquired additional equity-based compensation through dividend equivalents on existing restricted stock units. On December 8, 2025, the director received 4 dividend equivalent restricted stock units, each representing the right to receive one share of Class A common stock at an exercise price of $0. These dividend equivalents accrue on restricted stock units and vest proportionately with them, with the related restricted stock units scheduled to vest on the earlier of May 20, 2026 or the date of the annual meeting following the grant date. After this transaction, the director beneficially owned 2,801 restricted stock units and related dividend equivalents in total, all held directly.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

UL Solutions Inc. reported insider equity activity by its President and CEO, who is also a director. On 12/08/2025, the reporting person accrued dividend equivalent rights tied to existing restricted stock units. Two entries each reflect 71 restricted stock units credited at a price of $0, increasing the derivative holdings associated with the company’s Class A common stock.

Each dividend equivalent right represents a contingent right to receive one share of Class A common stock and accrues on restricted stock units already held. These rights vest proportionately with the underlying restricted stock units, which vest in three equal installments on the first, second, and third anniversaries of May 1, 2024 and April 1, 2025, as applicable. Following these transactions, the filings show updated beneficial ownership amounts of derivative securities held directly.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

UL Solutions Inc. director reports additional deferred stock units linked to dividends. A board member of UL Solutions Inc. (ticker ULS) filed a Form 4 for dividend equivalent rights that accrued on existing deferred restricted stock units. On 12/08/2025, the director was credited with 8 and 4 additional deferred restricted stock units at a price of $0, each representing the right to receive one share of Class A common stock in the future.

The filing explains that these dividend equivalent rights accrue when the company pays dividends and vest in step with the underlying deferred restricted stock units. One grant vested on May 1, 2025, and another will vest on the earlier of May 20, 2026 or the next annual meeting after grant. Following these credits, the director beneficially holds 4,954 and 2,801 deferred restricted stock units and related dividend equivalents, which are expected to be settled in shares under the company’s Non-Employee Director Deferred Compensation Plan.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

UL Solutions Inc. executive reports routine equity award adjustments. The company’s EVP & Chief Human Resources Officer filed a Form 4 reporting small grants of dividend equivalent rights tied to existing restricted stock units (RSUs) on Class A common stock. These dividend equivalents accrued as of December 8, 2025 and give the holder the right to receive one share of Class A common stock for each right when the related RSUs vest. The RSUs and their associated dividend equivalents vest in three equal installments on the first, second and third anniversaries of May 1, 2024 and April 1, 2025, respectively. Following these transactions, the executive beneficially owns a few thousand RSUs and related dividend equivalents, all held directly.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

UL Solutions Inc. reported insider equity activity involving dividend-equivalent rights on restricted stock units (RSUs). On 12/08/2025, an executive serving as Executive Vice President & Chief Transformation Officer acquired additional derivative securities in the form of dividend-equivalent rights tied to existing RSU awards, all at a price of $0 per unit.

Each dividend-equivalent right represents a contingent right to receive one share of UL Solutions’ Class A common stock and accrues on RSUs already held. These rights vest proportionately with the underlying RSUs, which vest in three equal installments on the first, second, and third anniversaries of specific grant dates, including May 1, 2024, January 1, 2025, and April 1, 2025. Following the reported transactions, the executive beneficially owns several blocks of RSUs and related dividend-equivalent rights, such as 2,593, 3,030, and 2,315 derivative securities, all held directly.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

UL Solutions Inc. director reported routine equity compensation activity involving dividend-equivalent rights linked to deferred restricted stock units. On December 8, 2025, the director acquired derivative securities in the form of deferred restricted stock units that track the company’s Class A common stock at a price of $0 per unit.

One block of dividend-equivalent rights relates to deferred restricted stock units that vested on May 1, 2025 and will be settled in Class A common shares at a time chosen under the company’s Non-Employee Director Deferred Compensation Plan. Another block relates to deferred restricted stock units that will vest on the earlier of May 20, 2026 or the next annual meeting following the grant date, and are also expected to be settled in Class A common shares under the same plan.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

UL Solutions Inc. (ULS) insider Form 4 details show that a Senior Vice President and Chief Accounting Officer received additional equity-linked awards in the form of dividend equivalent rights on restricted stock units (RSUs) on 12/08/2025. Each dividend equivalent right represents a contingent right to receive one share of Class A common stock and accrues on RSUs already held.

Following the transactions, one RSU award, together with its accrued dividend equivalents, covers 1,458 shares of Class A common stock, and another RSU award, together with its accrued dividend equivalents, covers 1,302 shares. One set of RSUs vests in three equal installments on the first, second and third anniversaries of May 1, 2024, and the other set vests in three equal installments on the first, second and third anniversaries of April 1, 2025. The reported derivative securities carry an exercise price of $0, reflecting their nature as equity-based compensation rather than open-market purchases.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

How many UL Solutions (ULS) SEC filings are available on StockTitan?

StockTitan tracks 116 SEC filings for UL Solutions (ULS), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for UL Solutions (ULS)?

The most recent SEC filing for UL Solutions (ULS) was filed on December 10, 2025.

ULS Rankings

ULS Stock Data

17.01B
76.47M
Specialty Business Services
Services-testing Laboratories
Link
United States
NORTHBROOK

ULS RSS Feed